Literature DB >> 1705281

T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism.

D J Moss1, S R Burrows, G D Baxter, M F Lavin.   

Abstract

Epstein-Barr virus-specific cytotoxic T lymphocyte clones were shown to be an effective target for their own lysis when incubated in the presence of their specific epitopes but not in the presence of irrelevant epitopes. The mode of cell killing appeared to be by apoptosis and was prevented by previously described inhibitors of the process. Degranulation, as measured by serine esterase activity, was involved in this form of T cell-T cell killing. This is the first report of T cell-T cell killing by apoptosis and is only observed in the presence of a specific epitope. This result may be of significance in the use of peptide-based vaccines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705281      PMCID: PMC2118827          DOI: 10.1084/jem.173.3.681

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.

Authors:  C Nagler-Anderson; M Lichtenheld; H N Eisen; E R Podack
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

Review 2.  Multiple mechanisms of lymphocyte-mediated killing.

Authors:  J D Young; C C Liu
Journal:  Immunol Today       Date:  1988-05

3.  Cell-mediated and glucocorticoid-mediated target cell lysis do not appear to share common pathways.

Authors:  G Dennert; C Landon; M Nowicki
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

4.  Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes.

Authors:  D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  The most efficient cytotoxic T lymphocytes are the least susceptible to lysis.

Authors:  M Skinner; J Marbrook
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

6.  Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.

Authors:  C Nagler-Anderson; C R Verret; A A Firmenich; M Berne; H N Eisen
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 7.  Cytotoxic T-lymphocytes. How do they function?

Authors:  G Berke
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules.

Authors:  E R Podack; J D Young; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Cell death by apoptosis in acute leukaemia.

Authors:  G D Baxter; R J Collins; B V Harmon; S Kumar; R L Prentice; P J Smith; M F Lavin
Journal:  J Pathol       Date:  1989-06       Impact factor: 7.996

10.  Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules.

Authors:  C R Verret; A A Firmenich; D M Kranz; H N Eisen
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  15 in total

1.  Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing.

Authors:  S R Burrows; A Suhrbier; R Khanna; D J Moss
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

Review 2.  Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Authors:  D J Moss; I S Misko; T B Sculley; A Apolloni; R Khanna; S R Burrows
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.

Authors:  R Khanna; S R Burrows; A Neisig; J Neefjes; D J Moss; S L Silins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

5.  Resistance of actin to cleavage during apoptosis.

Authors:  Q Song; T Wei; S Lees-Miller; E Alnemri; D Watters; M F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

6.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

7.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

Authors:  S P Lee; W A Thomas; R J Murray; F Khanim; S Kaur; L S Young; M Rowe; M Kurilla; A B Rickinson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.

Authors:  Luka Cicin-Sain; Zsolt Ruzsics; Juergen Podlech; Ivan Bubić; Carine Menard; Stipan Jonjić; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 10.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.